Lineage-Specific RUNX2 Super-Enhancer Activates MYC and Promotes the Development of Blastic Plasmacytoid Dendritic Cell Neoplasm

Nature Communications - United Kingdom
doi 10.1038/s41467-019-09710-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Blastic Plasmacytoid Dendritic Cell Neoplasm

Anais Brasileiros de Dermatologia
Dermatology
2013English

Blastic Plasmacytoid Dendritic Cell Neoplasm

Kansas Journal of Medicine
2014English

Pseudo-Rosette Forming Blastic Plasmacytoid Dendritic Cell Neoplasm

Turkish Journal of Haematology
Hematology
2020English

Blastic Plasmacytoid Dendritic Cell Neoplasm With Leukemic Progression

Journal of Medical Cases
2012English

Blastic Plasmacytoid Dendritic Cell Neoplasm With Unusual Morphology, MYC Rearrangement and TET2 and DNMT3A Mutations

British Journal of Haematology
Hematology
2018English

The Distinctive Cytology and Disease Evolution of Blastic Plasmacytoid Dendritic Cell Neoplasm

American Journal of Hematology
Hematology
2018English

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report of a Rare Leukemic Variant

2020English

Ileocecal Mucosal Involvement of Blastic Plasmacytoid Dendritic Cell Neoplasm Without Skin Lesions

The Korean Journal of Medicine
2018English

Gemcitabine and Docetaxel as a Novel Treatment Regimen for Blastic Plasmacytoid Dendritic Cell Neoplasm

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy